[9] In summary, while NAD+ Injection is a broadly applicable metabolic therapy, it should not be used by anyone allergic to it, and it is generally avoided in pregnant women, cancer patients, or those with serious chronic diseases, absent compelling medical rationale
The agency determines whether to accept, modify, or reject each recommendation
Manufactured in the USA and supplied in a sealed 30 mL vial
Blumenschein GR, Mills GB, Gonzalez-Angulo AM
10 In contrast, primary total knee arthroplasty (TKA) had an incidence rate of 429/100,000, 11 and recent projections estimate an 85% increase in TKAs by 2030